{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:58:52Z","timestamp":1787896732076,"version":"build-2784847793"},"reference-count":27,"publisher":"European Respiratory Society (ERS)","issue":"153","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2019,6,3]]},"published-print":{"date-parts":[[2019,9,30]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Debulking surgery and hyperthermic intrathoracic chemotherapy (HITHOC) has been successfully used in the treatment of thoracic tumours. Few authors report on the feasibility of its use in patients with lung cancer and malignant pleural effusion. The aim of this study was to evaluate the efficacy and results of debulking surgery and HITHOC in the treatment of selected patients with nonsmall cell lung cancer (NSCLC) and malignant pleural effusion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic review was conducted in MEDLINE in accordance with PRISMA guidelines. The word search included: \u201chyperthermic intrathoracic chemotherapy and\/or HITHOC or hyperthermic intrapleural\u201d. Inclusion criteria were only those studies reporting a sufficient amount of data on HITHOC and surgery for lung cancer. Single case reports and review articles were excluded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>20 articles were selected as they related to the topic of HITHOC and lung cancer. Most were from China (n=8) and Japan (n=6). Only four out of the 20 articles had sufficient data for this review. In total, data for 21 patients were collected. Debulking surgery ranged from wedge resection to pneumonectomy and pleurectomy. Mean survival was 27\u2005months and median survival was 18\u2005months (range 1\u201374\u2005months). 13 patients out of 21 (62%) were alive at 1\u2005year and six (28.5%) were alive at 2\u2005years. 10 patients were still alive at the time of the respective publication in the 21 patients included. Systemic toxicity and treatment-related mortality were nil. There were insufficient data to perform a meta-analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although reported survival in this systematic review is encouraging, available evidence concerning debulking surgery and HITHOC in N0\u2013N1 NSCLC with malignant pleural effusion is weak. Better evidence in the form of a randomised controlled trial is mandatory.<\/jats:p><\/jats:sec>","DOI":"10.1183\/16000617.0018-2019","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T15:46:33Z","timestamp":1564587993000},"page":"190018","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Does cytoreduction surgery and hyperthermic intrathoracic chemotherapy prolong survival in patients with N0\u2013N1 nonsmall cell lung cancer and malignant pleural effusion?"],"prefix":"10.1183","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6272-8983","authenticated-orcid":false,"given":"Marcello","family":"Migliore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Nardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"2024102403400937000_28.153.190018.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200504-531OE"},{"issue":"Suppl. 24","key":"2024102403400937000_28.153.190018.2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2217\/fon.15.286","article-title":"Pleurectomy\/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience","volume":"11","author":"Migliore","year":"2015","journal-title":"Future Oncol"},{"issue":"Suppl. 2","key":"2024102403400937000_28.153.190018.3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/fon.14.256","article-title":"Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience","volume":"11","author":"Migliore","year":"2015","journal-title":"Future Oncol"},{"key":"2024102403400937000_28.153.190018.4","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jtcvs.2017.09.162","article-title":"Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: is main tumor resection beneficial for prognosis?","volume":"155","author":"Li","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024102403400937000_28.153.190018.5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cllc.2011.05.006","article-title":"Results of a surgical resection for patients with stage IV non-small-cell lung cancer","volume":"13","author":"Hanagiri","year":"2012","journal-title":"Clin Lung Cancer"},{"key":"2024102403400937000_28.153.190018.6","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000554"},{"key":"2024102403400937000_28.153.190018.7","doi-asserted-by":"crossref","first-page":"e5532","DOI":"10.1097\/MD.0000000000005532","article-title":"Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: a systematic review and meta-analysis","volume":"96","author":"Zhou","year":"2017","journal-title":"Medicine"},{"key":"2024102403400937000_28.153.190018.8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.rmed.2013.01.010","article-title":"Intrapleural hyperthermic perfusion chemotherapy in subjects with metastatic pleural malignancies","volume":"107","author":"I\u015f\u0131k","year":"2013","journal-title":"Respir Med"},{"key":"2024102403400937000_28.153.190018.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-9293(03)00197-X"},{"key":"2024102403400937000_28.153.190018.10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601000"},{"key":"2024102403400937000_28.153.190018.11","first-page":"372","article-title":"The effects of heat and radiation on cancers implanted on the feet of mice","volume":"23","author":"Grile","year":"1963","journal-title":"Cancer Res"},{"key":"2024102403400937000_28.153.190018.12","first-page":"1165","article-title":"In vitro thermochemotherapy of human colon cancer cells with cisdichlorodiamineplatinium","volume":"40","author":"Barlogie","year":"1980","journal-title":"Cancer Res"},{"key":"2024102403400937000_28.153.190018.13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000227208","article-title":"A new device for the treatment of pleural malignancies: intrapleural chemohyperthermia preliminary report","volume":"50","author":"Carry","year":"1993","journal-title":"Oncology"},{"key":"2024102403400937000_28.153.190018.14","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs418"},{"key":"2024102403400937000_28.153.190018.15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.2.480"},{"key":"2024102403400937000_28.153.190018.16","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezv039"},{"key":"2024102403400937000_28.153.190018.17","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.18632\/oncotarget.6491","article-title":"EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"2024102403400937000_28.153.190018.18","doi-asserted-by":"publisher","DOI":"10.2147\/clep.s17191"},{"key":"2024102403400937000_28.153.190018.19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.21037\/jovs.2018.06.08","article-title":"A pragmatic view of the usefulness of video-mediastinoscopy in the modern era","volume":"4","author":"Migliore","year":"2018","journal-title":"J Vis Surg"},{"key":"2024102403400937000_28.153.190018.20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1510\/icvts.2009.225110","article-title":"Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination","volume":"10","author":"Kimura","year":"2010","journal-title":"Interact Cardiovascular Thorac Surg"},{"key":"2024102403400937000_28.153.190018.21","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.athoracsur.2004.05.025","article-title":"Intrapleural hyperthermic perfusion with chemotherapy increases apoptosis in malignant pleuritis","volume":"78","author":"Matsuzaki","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"2024102403400937000_28.153.190018.22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.21037\/jtd.2017.04.65","article-title":"Intrapleural perfusion thermo-chemotherapy for pleural effusion caused by lung carcinoma under VATS","volume":"9","author":"Hu","year":"2017","journal-title":"J Thorac Dis"},{"key":"2024102403400937000_28.153.190018.23","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.21037\/jtd.2016.06.04","article-title":"Clinical outcomes of cytoreductive surgery combined with intrapleural perfusion of hyperthermic chemotherapy in advanced lung adenocarcinoma with pleural dissemination","volume":"8","author":"Yi","year":"2016","journal-title":"J Thorac Dis"},{"key":"2024102403400937000_28.153.190018.24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/02656736.2013.829247","article-title":"Cytoreductive surgery and post-operative heated pleural chemotherapy for the management of pleural surface malignancy","volume":"29","author":"Kodama","year":"2013","journal-title":"Int J Hyperthermia"},{"key":"2024102403400937000_28.153.190018.25","first-page":"415","article-title":"Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age \u2013 challenges and opportunities","volume":"4","author":"Rami-Porta","year":"2015","journal-title":"Transl Lung Cancer Res"},{"key":"2024102403400937000_28.153.190018.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2015.09.009"},{"key":"2024102403400937000_28.153.190018.27","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.21037\/jtd.2019.05.25","article-title":"Clinical factors affecting the survival of patients diagnosed with non-small cell lung cancer and metastatic malignant pleural effusion, treated with hyperthermic intrathoracic chemotherapy or chemical talc pleurodesis: a single center, prospective, randomized trial","volume":"11","author":"Kleontas","year":"2019","journal-title":"J Thorac Dis"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0018-2019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:01:05Z","timestamp":1740373265000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0018-2019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":27,"journal-issue":{"issue":"153","published-online":{"date-parts":[[2019,7,31]]},"published-print":{"date-parts":[[2019,9,30]]}},"alternative-id":["10.1183\/16000617.0018-2019"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0018-2019","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,31]]}}}